Skip to main content
Contact
Login
Our Company
Our Company
Mission
Leadership
Clinical Studies
Clinical Studies
ECLIPSE
GRECO-Breast Cancer
Solutions
Solutions
Treatment Selection
Residual Disease & Recurrence Monitoring
Early Detection
Biopharma Solutions
International
Investors
Investors
Media
Media
Press Releases
Resources and Media Assets
Contacts
Careers
Careers
Join Our Mission
Making Their Mark
Our Values
Benefits
Jobs
Press Releases
Investors Menu
Home
Press Releases
Events & Presentations
Events
Presentations
Stock Information
Stock Quote & Chart
Analyst Coverage
Financials
Quarterly Results
Annual Reports
SEC Filings
Corporate Governance
Governance Documents
Leadership
Board of Directors
Committee Composition
Resources
Investor FAQs
Investor Email Alerts
Investor Contacts
Normal
Press Release RSS Feed (opens in new window)
Press release year list
2021
2020
2019
2018
2017
December 20, 2018
Guardant Health to Present at the 37th Annual J.P. Morgan Healthcare Conference
December 13, 2018
Guardant Health Partners with AstraZeneca to Develop Blood-Based Companion Diagnostic Tests for Tagrisso and Imfinzi
November 19, 2018
Guardant Health Reports Third Quarter 2018 Financial Results
November 13, 2018
Guardant Health To Report Third Quarter Financial Results on November 19, 2018
October 19, 2018
Guardant Health Presents Data on Immunotherapy-related Biomarkers MSI and TMB in blood of advanced cancer patients at European Society of Medical Oncology Annual Meeting
October 16, 2018
Lung Cancer Study Published in JAMA Oncology Shows Guardant360 Outperforms Tissue Biopsy Alone in Identification of Targetable Mutations
October 9, 2018
Guardant Health Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
October 3, 2018
Guardant Health Announces Pricing of Initial Public Offering
September 5, 2018
SLLIP Study Meets Primary Endpoint, Finds the Guardant360 Assay Performs Similar to Standard-of-Care Tissue Testing in Advanced NSCLC, Investigators to Report at WCLC
July 18, 2018
Foundation Medicine and Guardant Health Agree to Settle Patent Infringement Lawsuit
July 12, 2018
Guardant Health Appoints Leena Das-Young to Lead Efforts to Develop Liquid Biopsy Products for Early-Stage Cancer Applications
July 12, 2018
Guardant Health Announces Medicare Coverage for the Guardant360 Assay in Non-Small Cell Lung Cancer
May 23, 2018
Guardant Health to Present 29 Abstracts at ASCO Advancing the Science of Liquid Biopsy Across Multiple Indications and Applications
April 26, 2018
Guardant Health Publishes Extensive Validation of Guardant360® Assay Comprising Largest-Published Blood-Tissue Comparison
April 13, 2018
Guardant Health to Present Validation Data for the GuardantOMNI™ assay
March 13, 2018
Foundation Medicine and Guardant Health Agree to Resolve False Advertising Lawsuit
March 12, 2018
Guardant Health and National Cancer Center East Japan Announce Liquid Biopsy Arm of GI Cancer Trial
March 12, 2018
Guardant Health and National Cancer Center East Japan Announce Liquid Biopsy Arm of Lung Cancer Trial
February 15, 2018
The Guardant360® Assay Receives Expedited Access Pathway Designation for Breakthrough Devices from FDA